Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple MyelomaBlood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseRecruitingPhase 22026-06-04NCT06974786

3 results · Page 1 of 1

Swipe the table sideways for more columns.

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Colorado Blood Cancer InstituteDenverUnited States178
Medical College of WisconsinMilwaukeeUnited States483
Oncology Hematology CareCincinnatiUnited States13
Scri Oncology PartnersNashvilleUnited States156
The Ohio State University- The James Cancer Hospital and Solove Research InstituteColumbusUnited States1
University of Alabama at BirminghamBirminghamUnited States247
University of IowaIowa CityUnited States284
University of North CarolinaChapel HillUnited States101
University of Texas SouthwesternDallasUnited States73
University of Wisconsin Clinical Science CenterMadisonUnited States14
Virginia Oncology AssociatesNorfolkUnited States73